FDA 21 CFR Part 820 Quality System Regulation
什么是FDA 21 CFR第820部分质量系统法规？
FDA 21 CFR第820部分医疗设备涵盖了用于设计，制造，包装，标签，存储，安装和维修医疗设备中使用的工艺和控制设备。根据第820部分，美国FDA对制造商进行了检查，但是，没有第820部分的认证流程，仅评估遵守要求。188金宝搏网站靠谱吗操纵策略师对现有系统进行初步差距分析，以确定质量系统的开发程度。我们提供21 CFR 820培训，在其中我们指导客户通过文档，并帮助他们通过公司的各种职能有效地实施它。我们还进行了模拟审核，以测试第820部分要求实施的有效性。我们还向客户提供了调查后指南，以帮助他们关闭审计期间观察到的任何不合格。FDA 21 CFR第820部分帮助制造商构建和遵循质量系统，以确保其产品始终满足适用的要求和规格。
FDA QSR Compliance for medical device manufacturers
FDA调节产品（食品，药物，生物制剂和设备）的质量系统被称为当前良好的制造实践。首先，联邦食品，药物和化妆品法第520（f）条，FDA 21 CFR Part 820（QSR 21 CFR Part 820），首先授权了美国FDA 21 CFR第820部分（21 CFR第820部分）对设备的CGMP要求。是USFDA当前良好的制造（CGMP）对医疗设备制造商的要求。The FDA 21 CFR part 820 also known as Quality System Regulation i.e. FDA QSR which outlines current good manufacturing practice (CGMP) regulations that control the techniques used in and the efficiency and controls used for, the manufacturing, labelling, packaging, storage, installation,在美利坚合众国的设计和服务预定的所有完成的医疗设备的设计和维修。上述要求是为了确保医疗设备由支持FDA（食品和药物管理局）检查的医疗设备制造商安全有效，以确保FDA QSR（质量系统法规）21 CFR第820部分合规性。
Operon Strategist isFDA 510 k ClearanceAnd Approval helps the clients to register SBU (Small Business Unit), if applicable. Take out the testing requirement of the product, creation of the dossier, resolving the queries and after completion of all the activities, the client receives the US FDA 510 k approval.
FDA 21 CFR Part 820 – Quality System Regulations
Are you prepared to sell your medical devices in the United States? Provided that this is true, your organization must conform to the US FDA QSR (Quality System Regulation), particularly known as 21 CFR Part 820. Regardless of the possibility that you as of now have a quality management system must meet this regulation before you can sell your device.
FDA 21 CFR部分820.30设计控制要求
After conceptualizing a new medical device, the next step in its product advancement is the manufacturing plant layout design. This is the most important stage in the advancement of a medical device since a defective plan may prompt it being inadequate or dangerous (that is, not affirmed or cleared by the administrative organization). At the design stage, an outline FDA 21 CFR Part 820 design control process should be started and actualized as a feature of the quality system requirement. Generally, outline controls are straightforward and logical steps to ensure that what you develop is what you meant to develop and that the last item lives up to your client’s needs and desires.
We are amedical device consulting firmassisting companies and medical device manufacturers by providing consultancy services that support the registration of药物装备组合产品. We have experience with each constituent part and the GMP regulations that together form the basis for their development and manufacture: Drug (21 CFR 210 and 211), Device (FDA 21 CFR part 820) and Combination Products (21 CFR Part 4).
常问问题
Design Control labels the implementation of a formalistic technique to the ways of product development activities. It is often necessary by regulation for the appliance of such practice when designing and developing products within regulated industries e.g. medical devices. The Food and Drug Administration FDA has stated that medical device manufacturers that want to marketized certain classifications of medical devices in the USA follow design control requirements (21 CFR 820.30). Few firms regard Risk Management and Design Control as they are linked together but they follow separate procedures, not actualizing that the relation between the user needs, design inputs, dangers and dangerous circumstances. Design control conditions that when the suppliers or manufacturers get a product to design controls they may discover and maintain the correct documentation to assure the specified design requirements are.